1-44800486-T-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_004073.4(PLK3):ā€‹c.23T>Cā€‹(p.Leu8Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,432,244 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.00011 ( 1 hom., cov: 31)
Exomes š‘“: 0.0000070 ( 0 hom. )

Consequence

PLK3
NM_004073.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.228
Variant links:
Genes affected
PLK3 (HGNC:2154): (polo like kinase 3) The protein encoded by this gene is a member of the highly conserved polo-like kinase family of serine/threonine kinases. Members of this family are characterized by an amino-terminal kinase domain and a carboxy-terminal bipartite polo box domain that functions as a substrate-binding motif and a cellular localization signal. Polo-like kinases are important regulators of cell cycle progression. This gene has also been implicated in stress responses and double-strand break repair. In human cell lines, this protein is reported to associate with centrosomes in a microtubule-dependent manner, and during mitosis, the protein becomes localized to the mitotic apparatus. Expression of a kinase-defective mutant results in abnormal cell morphology caused by changes in microtubule dynamics and mitotic arrest followed by apoptosis. [provided by RefSeq, Sep 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14445987).
BS2
High AC in GnomAd4 at 17 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLK3NM_004073.4 linkuse as main transcriptc.23T>C p.Leu8Pro missense_variant 1/15 ENST00000372201.5 NP_004064.2 Q9H4B4
PLK3XM_047444455.1 linkuse as main transcriptc.23T>C p.Leu8Pro missense_variant 1/13 XP_047300411.1
PLK3XM_047444463.1 linkuse as main transcriptc.23T>C p.Leu8Pro missense_variant 1/9 XP_047300419.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLK3ENST00000372201.5 linkuse as main transcriptc.23T>C p.Leu8Pro missense_variant 1/151 NM_004073.4 ENSP00000361275.4 Q9H4B4
PLK3ENST00000465443.5 linkuse as main transcriptn.99T>C non_coding_transcript_exon_variant 1/145

Frequencies

GnomAD3 genomes
AF:
0.000113
AC:
17
AN:
151090
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000414
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000702
AC:
9
AN:
1281154
Hom.:
0
Cov.:
32
AF XY:
0.00000792
AC XY:
5
AN XY:
631172
show subpopulations
Gnomad4 AFR exome
AF:
0.000316
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000190
GnomAD4 genome
AF:
0.000113
AC:
17
AN:
151090
Hom.:
1
Cov.:
31
AF XY:
0.000108
AC XY:
8
AN XY:
73804
show subpopulations
Gnomad4 AFR
AF:
0.000414
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000147

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 07, 2024The c.23T>C (p.L8P) alteration is located in exon 1 (coding exon 1) of the PLK3 gene. This alteration results from a T to C substitution at nucleotide position 23, causing the leucine (L) at amino acid position 8 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.086
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
19
DANN
Benign
0.83
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.42
T
M_CAP
Pathogenic
0.62
D
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-0.87
N
REVEL
Benign
0.098
Sift
Benign
0.074
T
Sift4G
Benign
0.27
T
Polyphen
0.0
B
Vest4
0.16
MutPred
0.21
Gain of relative solvent accessibility (P = 0.0166);
MVP
0.57
MPC
0.63
ClinPred
0.068
T
GERP RS
0.12
Varity_R
0.15
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs929413783; hg19: chr1-45266158; API